DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001
Condition(s):CataractLast Updated:May 26, 2021Completed
Hide Studies Not Open or Pending
Condition(s):CataractLast Updated:May 26, 2021Completed
Condition(s):Diabetic Macular EdemaLast Updated:June 22, 2020Completed
Condition(s):Ocular Disease Requiring SurgeryLast Updated:January 29, 2021Unknown status
Condition(s):Macular Edema; UveitisLast Updated:March 11, 2015Completed
Condition(s):Post-Surgical Ocular Pain; Post-Surgical Ocular InflammationLast Updated:October 19, 2020Unknown status
Condition(s):CataractLast Updated:January 28, 2022Recruiting
Condition(s):Diabetic Macular Edema; Diabetic Retinopathy; Retinal IschemiaLast Updated:March 18, 2020Unknown status
Condition(s):Diabetic Macular Edema; Epiretinal MembraneLast Updated:May 16, 2018Completed
Condition(s):Macular Edema; Central Retinal Vein OcclusionLast Updated:December 14, 2015Unknown status
Condition(s):Anterior Chamber Inflammation; Ocular Pain; Corneal Edema; Corneal Defect; Penetrating KeratoPlasty; Nuclear Cataract; Cortical Cataract; Cataract SenileLast Updated:July 26, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.